Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals

BACKGROUND: Ceftazidime-avibactam has in vitro activity against some carbapenem-resistant gram-negative infections (GNIs), and therefore may be a useful alternative to more toxic antibiotics such as colistin. Understanding ceftazidime-avibactam uptake and usage patterns would inform hospital formula...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Infect Dis
Glavni autori: Strich, Jeffrey R, Ricotta, Emily, Warner, Sarah, Lai, Yi Ling, Demirkale, Cumhur Y, Hohmann, Samuel F, Rhee, Chanu, Klompas, Michael, Palmore, Tara, Powers, John H, Dekker, John P, Adjemian, Jennifer, Matsouaka, Roland, Woods, Christopher W, Danner, Robert L, Kadri, Sameer S
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Major Articles and Commentaries
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7884805/
https://ncbi.nlm.nih.gov/pubmed/32107536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa061
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items